How AstraZeneca’s $400bn tie-up with US rival Bristol Myers unravelled
- Posted on August 11, 2026
- By Financial Times
- 0 Views
- 1 min read
In brief
Generating AI summary…
How AstraZeneca’s $400bn tie-up with US rival Bristol Myers unravelled
A merger between the giant drugmakers would have marked a return to pharma megadeals
